Katrien De Bock

Prof. Dr. at ETH Zürich

ETH Zürich
Country flag
Switzerland

Research Interests

Explore related searches

Contact this professor

LinkedIn
ORCID
Google Scholar
Academic Page

Recent Grants

Grant: Close

Endothelial metabolism to promote muscle revascularization and regeneration

Open Date: 2022-04-01

Close Date: 2026-03-31

Positions (1)

Publisher
source

Katrien De Bock

University Name
.

ETH Zürich

Bioinformatician – Single-Cell Omics in Vascular & Skeletal Muscle Biology

ETH Zurich is offering a fixed-term postdoctoral-level bioinformatician position in the Laboratory of Exercise and Health , led by Prof. Dr. Katrien De Bock at the Department of Health Sciences and Technology (D-HEST). The role focuses on single-cell and spatial omics in the context of vascular biology , skeletal muscle physiology , and metabolism . The lab investigates how the muscle microvascular niche and specialized endothelial cell subpopulations interact with macrophages, pericytes, fibro-adipogenic progenitors, and other niche cells to maintain muscle homeostasis. The project combines human patient samples , mouse genetic models , single-cell and spatial transcriptomics , and CRISPR-based perturbation and cell-cell interaction tracing to understand how disrupted niche communication contributes to muscle dysfunction. The successful candidate will lead the full single-cell and spatial transcriptomics workflow and work closely with PhD students, postdocs, and Prof. De Bock. Responsibilities include scRNA-seq analysis of human and mouse skeletal muscle samples, cell-state annotation, cross-species integration, multi-omics integration with spatial transcriptomics, ATAC-seq, metabolomics and multiplex imaging, cell-cell communication analysis, metabolic modeling, pseudobulk and differential expression analysis, in silico perturbation, and the development of reproducible bioinformatics pipelines and Shiny apps. Applicants should hold a PhD in bioinformatics, computational biology, computational genomics, or a related quantitative field . Strong hands-on experience with single-cell RNA-seq analysis is essential, and experience with spatial transcriptomics is highly desirable. The role also requires strong programming skills in R and/or Python , familiarity with Bioconductor/scverse tools, version control and collaborative development platforms such as GitHub/GitLab, and experience with high-performance computing . A genuine interest in skeletal muscle physiology and/or vascular biology, strong communication skills, team spirit, and advanced English proficiency are expected. The position offers access to state-of-the-art infrastructure at ETH Zurich, dedicated computational resources, and a highly collaborative, internationally oriented research environment. The salary is competitive and aligned with ETH Zurich regulations. ETH Zurich emphasizes equality, diversity, and an inclusive working culture. Application: Submit your application online via the ETH Zurich portal with a CV, a one-page motivation/research statement, and contact details of two references. Questions about the role may be directed to Prof. Dr. Katrien De Bock at [email protected] . Applications by email or post are not accepted. Institution: ETH Zurich, Switzerland. Deadline: not specified in the posting.

Articles (16)

Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma

Metastatic melanoma is either intrinsically resistant or rapidly acquires resistance to targeted therapy treatments, such as MAPK inhibitors (MAPKi). A leading cause of resistance to targeted therapy is a dynamic transition of melanoma cells from a proliferative to a highly invasive state, a phenomenon called phenotype switching. Mechanisms regulating phenotype switching represent potential targets for improving treatment of patients with melanoma. Using a drug screen targeting chromatin regulators in patient-derived three-dimensional MAPKi-resistant melanoma cell cultures, we discovered that PARP inhibitors (PARPi) restore sensitivity to MAPKis, independent of DNA damage repair pathways. Integrated transcriptomic, proteomic, and epigenomic analyses demonstrated that PARPis induce lysosomal autophagic cell death, accompanied by enhanced mitochondrial lipid metabolism that ultimately increases antigen presentation and sensitivity to T-cell cytotoxicity. Moreover, transcriptomic and epigenetic rearrangements induced by PARP inhibition reversed epithelial–mesenchymal transition-like phenotype switching, which redirected melanoma cells toward a proliferative and MAPKi-sensitive state. The combination of PARP and MAPKis synergistically induced cancer cell death both in vitro and in vivo in patient-derived xenograft models. Therefore, this study provides a scientific rationale for treating patients with melanoma with PARPis in combination with MAPKis to abrogate acquired therapy resistance. Significance: PARP inhibitors can overcome resistance to MAPK inhibitors by activating autophagic cell death and reversing phenotype switching, suggesting that this synergistic combination could help improve the prognosis of patients with melanoma.

Year:

2023

Collaborators (17)

Eling D. de Bruin

ETH Zürich

SWITZERLAND

Andrés A Urrutia

Universidad Autónoma de Madrid

SPAIN

Christoffer Clemmensen

Københavns Universitet

DENMARK

Mark Larance

Senior Lecturer

University of Sydney

AUSTRALIA

Olivier Braissant

-

SWITZERLAND

Jakob G Knudsen

Assistant professor

University of Copenhagen

DENMARK

Nicoline Resen Andersen

Københavns Universitet

DENMARK

Joachim Fandrey

Universitätsprofessor

Universität zu Köln Medizinische Fakultät

GERMANY

Ekaterina Khatchatourova

University of Bern

SWITZERLAND

Peter Carmeliet

Aarhus University

DENMARK

Erik A. Richter

Københavns Universitet

DENMARK

Christian Stockmann

-

SWITZERLAND

Laura Hinte

ETH Zürich

SWITZERLAND

Christophe Delecluse

Full professor

KU Leuven

BELGIUM

Michael O. Hottiger

University of Zurich

SWITZERLAND

Daniel Castellano-Castillo

Assistant Professor

University of Malaga

SPAIN

Francisco Javier Ruiz Ojeda

Universidad de Granada

SPAIN
Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI